We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Laurence Joseph Dineen Chair in Leukemia Research with Special Emphasis on Leukemia in Children and Young People
Deputy Physician-in-Chief, Translational Research, Memorial Hospital
Get To Know Me
I am a physician-scientist focused on researching and treating blood and bone marrow cancers, including acute myeloid leukemia and the chronic myeloproliferative neoplasms polycythemia vera, essential thrombocytosis, and primary myelofibrosis.
Taking care of people with leukemia during my residency and fellowship inspired my interest in the disease. I saw that while our treatments could be quite effective the first go-round, many leukemia patients relapse. That got me thinking about how we could better understand why leukemia develops and how we could create new, targeted treatments to improve outcomes.
Read more
When I am not running my research lab (more information on that here), I treat people with leukemia on an inpatient basis. I do approximately 30 procedures a year, most of which are bone marrow biopsies.
Most people feel overwhelmed when they are first diagnosed, so our job is to give them the information they need and to show them that a wholeteam of expertsis here to help them through the process. My hope is that patients leave our interactions feeling empowered and hopeful.
Outside of work, I love spending time with my family, playing tennis and squash, and rooting for the New York Mets!
Areas of Expertise
My Specialties
Leukemias
Myeloproliferative Neoplasms
Education & Honors
Education
MD, Johns Hopkins University School of Medicine
Residencies
Internal Medicine - Massachusetts General Hospital
Awards and Honors
Pershing Square Sohn Prize for Cancer Research (2014), Laurence Joseph Dineen Chair in Leukemia Research (2013), Leukemia and Lymphoma Society Scholar (2012), Boyer Award for Clinical Research, Memorial Sloan Kettering Cancer Center (2011), Howard Hughes Medical Institute Early Career Award (2007), American Society of Hematology Basic Research Fellow Award (2006), American Society of Clinical Oncology Young Investigator Award (2006), American Society of Hematology 2016 Scientific Program co-chair Medical and Scientific Advisory Board, Leukemia and Lymphoma Society
Fellowships
Hematology/Medical Oncology - Dana Farber Cancer Institute/Partners Cancer Care
Board Certifications
Internal Medicine
Hematology
Medical Oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
Aetna
In Network Coverage Type HMO, EPO PPO, POS, Transplant
Request an appointment by logging on to MyMSK or calling your doctor’s office. If you aren’t registered for MyMSK, call 646-227-2593 for your Enrollment ID.
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
We strive to keep reviews trustworthy, honest and fair.
Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Ross L. Levine discloses the following relationships and financial interests:
Ajax Therapeutics, Inc. Equity; Fiduciary Role / Position; Intellectual Property Rights; Professional Services and Activities (Uncompensated)
Anovia Biosciences, Inc Equity
AstraZeneca Professional Services and Activities
Auron Therapeutics, Inc. Equity; Professional Services and Activities (Uncompensated)
Bakx Therapeutics Equity
C4 Therapeutics Equity; Professional Services and Activities
Cure Breast Cancer Foundation Intellectual Property Rights
ECOG-ACRIN Cancer Research Group Professional Services and Activities (Uncompensated)
Epiphanes, Inc. Equity
Epizyme Intellectual Property Rights
Genome Quebec Professional Services and Activities
Goldman Sachs Professional Services and Activities
Imago Biosciences Equity
Incyte Professional Services and Activities
Isoplexis Corporation Equity; Professional Services and Activities (Uncompensated)
Janssen Pharmaceuticals, Inc. Professional Services and Activities
Jubilant Therapeutics Inc. Professional Services and Activities
Kurome Therapeutics, Inc. Equity; Professional Services and Activities
Mana Therapeutics, Inc. Equity; Professional Services and Activities
Mission Bio Equity; Professional Services and Activities
Prelude Therapeutics Equity; Professional Services and Activities
Qiagen Equity; Fiduciary Role / Position; Professional Services and Activities (Uncompensated)
Scorpion Therapeutics, Inc. Equity; Professional Services and Activities
Syndax Equity
The Mark Foundation Fiduciary Role / Position; Professional Services and Activities
Zentalis Pharmaceuticals Equity; Professional Services and Activities
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2022 through disclosure submission in spring 2023). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].
